You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 16, October 22, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  JAMA Patient Page
 This Article
 •PDF
 •Spanish PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •JAMA Patient Page
 •Endocrine Diseases
 •Diabetes Mellitus
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Type 1 Diabetes

Our bodies need fuel for proper function. Glucose (sugar) is the fuel that our cells use to produce energy. In order to process the sugar we eat in various foods, our bodies produce insulin. Insulin is a hormone made by beta cells, clusters of cells in the pancreas (an organ located in the upper abdomen). In type 1 diabetes, the beta cells in the pancreas are unable to make insulin because of autoimmune disease. This means that the body's immune system makes autoantibodies that attack and destroy the pancreatic beta cells. Type 2 diabetes is the result of the body's not being able to properly use the insulin made by the pancreas, and it occurs in adults and children who are overweight. Because type 1 diabetes usually starts in childhood, it is sometimes called juvenile diabetes. Type 1 diabetes is a serious illness that cannot be cured, but it can be treated and controlled. The October 22/29, 2003, issue of JAMA includes an article about type 1 diabetes.

CHARACTERISTICS OF UNTREATED TYPE 1 DIABETES

  • Thirst
  • Frequent urination
  • Weight loss
  • Poor infant growth
  • High blood glucose level


COMPLICATIONS OF TYPE 1 DIABETES

  • Diabetic ketoacidosis—a life-threatening medical condition, also known as diabetic coma, is caused by the body's need to break down fats for energy instead of using sugars
  • Kidney failure
  • Diabetic retinopathy—damage to the retina of the eye
  • Gastroparesis—the stomach does not empty properly, allowing partially digested food to accumulate
  • Diabetic neuropathy—loss of sensation and nerve control of body functions
  • Increased occurrence of infections
  • Poor circulation, especially in the feet and legs
  • Coronary heart disease


MANAGEMENT OF TYPE 1 DIABETES

  • Insulin injections—oral medications do not work
  • Diet
  • Exercise
  • Frequent checks of blood glucose levels
  • Management of other medical problems including high blood pressure and coronary heart disease
  • Screening for and early recognition of diabetes complications
  • Kidney dialysis or transplantation for kidney failure
  • Pancreas transplantation



FOR MORE INFORMATION


INFORM YOURSELF

To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on diabetes and the kidney was published in the June 25, 2003, issue; one on insulin was published in the May 7, 2003, issue; one on diabetes was published in the May 15, 2002, issue; one on type 2 diabetes in children was published in the September 26, 2001, issue; and one on managing type 2 diabetes was published in the January 12, 2000, issue.

Sources: National Institute of Diabetes & Digestive & Kidney Diseases; American Diabetes Association

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Any other print or online reproduction is subject to AMA approval. To purchase bulk reprints, call 718/946-7424.

TOPIC: DIABETES

Janet M. Torpy, MS, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor

JAMA. 2003;290:2216.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic Nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JAMA. 2003;290(16):2159-2167.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.